Clinical Trials

160 enrolled

Lymphoid

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT06364371 2025-12-18

Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer

106 enrolled

Pathologic Complete Response

NCT07166185 2025-09-10

NEOTRAPSCAL

70 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT06111807 2025-03-30

MRD-LUNG

248 enrolled

Thoracic

Pathologic Complete Response, Hypersensitivity, Lung Neoplasms, Neoplasm, Residual

NCT06889402 2025-03-21

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

Not yet recruiting

600 enrolled

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms, Recurrence

NCT06854107 2025-03-06

Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

225 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Pathologic Complete Response

NCT06794099 2025-01-27

Study on the Applicability of CCR Criteria in Rectal Cancer

177 enrolled

Pathologic Complete Response

NCT06755567 2025-01-01

Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma

Not yet recruiting

750 enrolled

Head & Neck

Pathologic Complete Response, Head and Neck Neoplasms

NCT06182657 2024-02-08

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

300 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Pathologic Complete Response

NCT05925751 2023-06-29

Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

100 enrolled

Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT04278274 2022-10-26

MR-AI-pCR

205 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT05534841 2022-09-10

Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer

99 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT04939103 2022-09-01

TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer

63 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT04457700 2022-04-18

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

218 enrolled

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05050890 2021-09-30

GIRO_ctDNA

38 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT04917263 2021-06-08

IMMUNOREACT2

544 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT04271657 2021-05-06

RPAI-pCR

100 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT03474341 2020-11-16

PRIDE

200 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms

NCT03426397 2020-07-29

"Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer

220 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT01430663 2020-04-20

Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples

87 enrolled

Pathologic Complete Response, Aspergillosis

NCT04273477 2020-02-18

MRAI-pCR

100 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT03601689 2018-07-26

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

84 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT01433926 2011-09-14

LongHer

114 enrolled